[3-(4-fluorophenyl)-6-oxo-1-phenyl-7H-pyrazolo[5,4-b]pyridin-5-yl]methyl-[[(2S)-oxolan-2-yl]methyl]azanium
C24H24FN4O2+ — CID 135617386
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-(4-fluorophenyl)-6-oxo-1-phenyl-7H-pyrazolo[5,4-b]pyridin-5-yl]methyl-[[(2S)-oxolan-2-yl]methyl]azanium
[3-(4-fluorophenyl)-6-oxo-1-phenyl-7H-pyrazolo[5,4-b]pyridin-5-yl]methyl-[[(2S)-oxolan-2-yl]methyl]azanium (PubChem CID 135617386) has the molecular formula C24H24FN4O2+ and a molecular weight of 419.48 g/mol. Its IUPAC name is [3-(4-fluorophenyl)-6-oxo-1-phenyl-7H-pyrazolo[5,4-b]pyridin-5-yl]methyl-[[(2S)-oxolan-2-yl]methyl]azanium.
Molecular Properties
| Compound Name | [3-(4-fluorophenyl)-6-oxo-1-phenyl-7H-pyrazolo[5,4-b]pyridin-5-yl]methyl-[[(2S)-oxolan-2-yl]methyl]azanium |
|---|---|
| PubChem CID | 135617386 |
| Molecular Formula | C24H24FN4O2+ |
| Molecular Weight | 419.48 g/mol |
| Exact Mass | 419.19 |
| IUPAC Name | [3-(4-fluorophenyl)-6-oxo-1-phenyl-7H-pyrazolo[5,4-b]pyridin-5-yl]methyl-[[(2S)-oxolan-2-yl]methyl]azanium |
| SMILES | O=c1[nH]c2c(cc1C[NH2+]C[C@@H]1CCCO1)c(-c1ccc(F)cc1)nn2-c1ccccc1 |
| InChI | InChI=1S/C24H23FN4O2/c25-18-10-8-16(9-11-18)22-21-13-17(14-26-15-20-7-4-12-31-20)24(30)27-23(21)29(28-22)19-5-2-1-3-6-19/h1-3,5-6,8-11,13,20,26H,4,7,12,14-15H2,(H,27,30)/p+1/t20-/m0/s1 |
| InChIKey | ICTSORLSKSUDPJ-FQEVSTJZSA-O |
| XLogP | 2.76 |
| TPSA | 76.52 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 419.48 |
| LogP ≤ 5 | 2.76 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135617386 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.